ZURA
Zura Bio·NASDAQ
--
--(--)
--
--(--)
ZURA fundamentals
During Q4 2025, Zura Bio (ZURA) reported revenue of --, a YoY change of 0.00%. Net income was -17.18M, a YoY change of -26.06%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Mar 10, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 18, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 33.04K -- | 19.14K -- | 321.86K -- | 514.50K -- | 7.82M +23565.97% | 927.00K +4743.01% | 1.07M +231.82% | 17.35M +3271.80% | 7.72M -1.28% | 33.91M +3557.50% | 10.19M +853.84% | 10.83M -37.59% | 8.38M +8.55% | 11.76M -65.32% | 19.32M +89.64% | 15.73M +45.30% | 19.25M +129.79% | 18.06M +53.60% | 19.52M +1.04% | 18.41M +17.03% | 75.25M -- |
Selling, General and Administrative Expenses | 33.04K -- | 19.14K -- | 321.86K -- | 514.50K -- | 319.00K +865.53% | 842.00K +4298.93% | 653.00K +102.88% | 1.66M +222.45% | 2.83M +788.71% | 5.67M +573.99% | 6.22M +852.83% | 3.91M +135.50% | 4.79M +68.82% | 6.22M +9.60% | 13.29M +113.60% | 6.49M +66.16% | 8.78M +83.45% | 9.36M +50.45% | 7.57M -43.03% | 7.46M +14.83% | 33.16M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | 888.54K -- | -- -- | -- -- | -- -- | 3.47M +290.86% | -- -- | -- -- | 6.22M -- | 3.91M +12.50% | 4.79M -- | 6.22M -- | 13.29M +113.60% | 6.49M +66.16% | 8.78M +83.45% | 9.36M +50.45% | 7.57M -43.03% | 7.46M +14.83% | 33.16M -- |
Research and Development Expenses | -- -- | -- -- | -- -- | -- -- | 7.50M -- | 85.00K -- | 415.00K -- | 15.69M -- | 4.88M -34.88% | 28.23M +33111.76% | 3.96M +855.42% | 6.92M -55.89% | 3.59M -26.43% | 5.54M -80.38% | 6.03M +52.06% | 9.24M +33.53% | 10.47M +191.51% | 8.70M +57.14% | 11.95M +98.18% | 10.96M +18.57% | 42.08M -- |
Operating Income | -33.04K -- | -19.14K -- | -321.86K -- | -514.50K -- | -7.82M -23565.97% | -927.00K -4743.01% | -1.07M -231.82% | -17.35M -3271.80% | -7.72M +1.28% | -33.91M -3557.50% | -10.19M -853.84% | -10.83M +37.59% | -8.38M -8.55% | -11.76M +65.32% | -19.32M -89.64% | -15.73M -45.30% | -19.25M -129.79% | -18.06M -53.60% | -19.52M -1.04% | -18.41M -17.03% | -75.25M -- |
Non-Operating Income (Loss) | 0 -- | -- -- | 6.11M -- | 1.63M -- | -- -- | 2.00K -- | -34.00K -100.56% | -139.00K -108.54% | -2.08M -- | -120.00K -6100.00% | 1.92M +5738.24% | 2.35M +1793.53% | 632.00K +130.44% | 1.43M +1291.67% | -1.38M -172.14% | 2.11M -10.49% | 1.81M +186.71% | 2.07M +44.69% | 1.48M +206.94% | 1.24M -41.34% | 6.60M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | 19.05K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | 10.24M -- | -- -- | -- -- | -- -- | -156.00K -101.52% | -- -- | -- -- | 119.00K -- | 960.00K +715.38% | -606.00K -- | -768.00K -- | -3.87M -3348.74% | 0 -100.00% | 0 +100.00% | 0 +100.00% | -- -- | 0 -- | -- -- |
Other Non-Operating Income (Loss) | 0 -- | -- -- | 6.11M -- | -8.63M -- | -- -- | 2.00K -- | -34.00K -100.56% | 9.00K +100.10% | -2.08M -- | -120.00K -6100.00% | 983.00K +2991.18% | 24.00K +166.67% | 23.00K +101.11% | 2.00K +101.67% | 22.00K -97.76% | -19.00K -179.17% | -5.00K -121.74% | 352.00K +17500.00% | -47.00K -313.64% | -40.00K -110.53% | 260.00K -- |
Net Interest Expense | 0 -- | -- -- | -29 -- | -22 -- | -- -- | -- -- | -- -- | -8.00K -36263.64% | -1.00K -- | -- -- | -815.00K -- | -1.37M -17025.00% | -1.22M -121400.00% | -2.20M -- | -2.46M -201.96% | -2.13M -55.18% | -1.82M -49.55% | -1.72M +21.81% | -1.53M +37.99% | -1.28M +39.98% | -6.34M -- |
Interest Income | 0 -- | -- -- | 29 -- | 22 -- | -- -- | -- -- | -- -- | 8.00K +36263.64% | 1.00K -- | -- -- | 815.00K -- | 1.37M +17025.00% | 1.22M +121400.00% | 2.20M -- | 2.46M +201.96% | 2.13M +55.18% | 1.82M +49.55% | 1.72M -21.81% | 1.53M -37.99% | 1.28M -39.98% | 6.34M -- |
Pretax Income From Continuing Operations | -33.04K -- | -19.14K -- | 5.79M -- | 1.11M -- | -7.82M -23565.97% | -925.00K -4732.56% | -1.10M -119.04% | -17.49M -1670.09% | -9.79M -25.27% | -34.02M -3578.38% | -8.27M -650.45% | -8.47M +51.55% | -7.75M +20.91% | -10.33M +69.64% | -20.70M -150.33% | -13.63M -60.80% | -17.44M -125.15% | -15.99M -54.84% | -18.04M +12.86% | -17.18M -26.06% | -68.65M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -33.04K -- | -19.14K -- | 5.79M -- | 1.11M -- | -7.82M -23565.97% | -925.00K -4732.56% | -1.10M -119.04% | -17.49M -1670.09% | -9.79M -25.27% | -34.02M -3578.38% | -8.27M -650.45% | -8.47M +51.55% | -7.75M +20.91% | -10.33M +69.64% | -20.70M -150.33% | -13.63M -60.80% | -17.44M -125.15% | -15.99M -54.84% | -18.04M +12.86% | -17.18M -26.06% | -68.65M -- |
Net Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.59M -- | 0 -- | 10.88M -- | 0 -- | 0 +100.00% | -- -- | -- -- | -- -- | -7.02M -- | -- -- | -- -- | -- -- | 30.70M +537.55% | -- -- |
Net Income Attributable to Owners of the Company | -33.04K -- | -19.14K -- | 5.79M -- | 1.11M -- | -7.82M -23565.97% | -925.00K -4732.56% | -1.10M -119.04% | -15.89M -1526.88% | -9.79M -25.27% | -44.90M -4754.05% | -8.27M -650.45% | -8.47M +46.68% | -7.75M +20.91% | -10.33M +77.00% | -20.70M -150.33% | -6.61M +22.01% | -17.44M -125.15% | -15.99M -54.84% | -18.04M +12.86% | -47.88M -624.55% | -99.35M -- |
Other Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 6.65M -- | -- -- | -- -- | 0 -- | -2.19M -133.00% | -7.02M -- | 2.34M -- | 2.24M -- | 2.44M +211.16% | 0 +100.00% | 0 -100.00% | 2.00M -10.85% | -2.00M -181.84% | -- -- |
Net Income Attributable to Common Stockholders | -33.04K -- | -19.14K -- | 5.79M -- | 1.11M -- | -7.82M -23565.97% | -925.00K -4732.56% | -1.10M -119.04% | -22.54M -2124.14% | -9.79M -25.27% | -44.90M -4754.05% | -8.27M -650.45% | -6.28M +72.15% | -730.00K +92.55% | -12.67M +71.79% | -22.94M -177.41% | -9.05M -44.12% | -17.44M -2289.32% | -15.99M -26.27% | -20.04M +12.66% | -45.88M -407.08% | -99.35M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -52.40M -- | -- -- | -- -- | -- -- | -68.65M -31.00% | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -60.56M -- | -- -- | -- -- | -- -- | -52.40M +13.47% | -- -- | -- -- | -- -- | -68.65M -31.00% | -- -- |
Basic EPS | -0.02 -- | -- -- | 0.39 -- | 0.06 -- | -72.40K -361977300.00% | -9.54 -- | -2.87 -835.90% | -1.31 -2283.33% | -2.76 +100.00% | -1.31 +86.27% | -0.18 +93.73% | -0.14 +89.31% | -0.02 +99.28% | -0.17 +87.02% | -0.26 -44.44% | -0.14 -- | -0.19 -850.00% | -0.17 -- | -0.21 +19.23% | -0.62 -342.86% | -1.19 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.18 -- | -- -- | -0.02 -- | -0.17 -- | -0.26 -44.44% | -- -- | -0.19 -850.00% | -0.17 -- | -0.21 +19.23% | -- -- | -- -- |
Diluted EPS | -0.02 -- | -- -- | 0.39 -- | -- -- | -72.40K -361977300.00% | -9.54 -- | -2.87 -835.90% | -- -- | -2.76 +100.00% | -1.31 +86.27% | -0.18 +93.73% | -- -- | -0.02 +99.28% | -0.17 +87.02% | -0.26 -44.44% | -- -- | -0.19 -850.00% | -0.17 -- | -0.21 +19.23% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.18 -- | -- -- | -0.02 -- | -0.17 -- | -0.26 -44.44% | -- -- | -0.19 -850.00% | -0.17 -- | -0.21 +19.23% | -- -- | -- -- |
You can ask Aime
What were the key takeaways from Zura Bio's earnings call?What is the revenue and EPS growth rate for Zura Bio year over year?What does Zura Bio do and what are its main business segments?What guidance did Zura Bio's management provide for the next earnings period?What were the key takeaways from Zura Bio’s earnings call?What factors drove the changes in Zura Bio's revenue and profit?What is Zura Bio's gross profit margin?Did Zura Bio beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
